期刊
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
卷 81-82, 期 -, 页码 27-33出版社
ELSEVIER
DOI: 10.1016/j.jpba.2013.03.020
关键词
Echinacoside; Hollow fiber liquid phase microextraction; HPLC; Parkinson's disease; Pharmacokinetics
资金
- National Natural Science Foundation of China (NSFC) [21102175]
A simple and solvent-minimized sample preparation technique based on two-phase hollow fiber liquid phase microextraction (HF-LPME) was developed and used to quantify the echinacoside in Parkinson's disease rat plasma following oral administration. Analysis was accomplished by reversed-phase high performance liquid chromatography (HPLC) with ultraviolet detection. The influence factors relevant to the HF-LPME processes were optimized. Under the optimized conditions, the preconcentration factor for echinacoside was 337. Calibration curves with reasonable linearity (r(2) >= 0.9998) were obtained in the range of 5-750 ng mL(-1). Intra-day and inter-day precision (RSD) were <= 5.43% and the limit of detection (LCD) for the analyte was 2.0 ng mL(-1) (S/N = 3). The validated method has been successfully applied for pharmacokinetic studies of echinacoside in Parkinson's disease (PD) rat plasma after oral administration. Crown Copyright (C) 2013 Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据